Watanabe, Mikiko

BMI and BMD: the potential interplay between obesity and bone fragility

Palermo, A., Tuccinardi, D., Defeudis, G., Watanabe, M., D’Onofrio, L., Lauria Pantano, A., Napoli, N., Pozzilli, P., & Manfrini, S. (2016) · International Journal of Environmental Research and Public Health

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 197

Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury

Desai, B. N., Singhal, G., Watanabe, M., Stevanovic, D., Lundasen, T., Fisher, F. M., Mather, M. L., Vardeh, H. G., Douris, N., Adams, A. C., et al. (2017) · Molecular Metabolism

Fibroblast Growth Factor ResearchAlcohol Consumption and Health Effects

Cited by 150

Sex difference in the safety and efficacy of bariatric procedures: a systematic review and meta-analysis

Risi, R., Rossini, G., Tozzi, R., Pieralice, S., Monte, L., Masi, D., Castagneto-Gissey, L., Gallo, I. F., Strigari, L., Casella, G., et al. (2022) · Surgery for Obesity and Related Diseases

Bariatric Surgery and OutcomesBody Contouring and Surgery

Cited by 68

Whey Protein, L-Leucine and Vitamin D Supplementation for Preserving Lean Mass during a Low-Calorie Diet in Sarcopenic Obese Women

Camajani, E., Persichetti, A., Watanabe, M., Contini, S., Vari, M., Di Bernardo, S., Faro, M., Lubrano, C., Gnessi, L., Caprio, M., et al. (2022) · Nutrients

Nutrition and Health in AgingMuscle metabolism and nutrition

Cited by 34

Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan

Tuccinardi, D., Masi, D., Watanabe, M., Zanghi Buffi, V., De Domenico, F., Berti, S., Cipriani, V., Manco, M., Manfrini, S., & Pagotto, U. (2025) · Journal of Endocrinological Investigation

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 29

Application of a Machine Learning Technology in the Definition of Metabolically Healthy and Unhealthy Status: A Retrospective Study of 2567 Subjects Suffering from Obesity with or without Metabolic Syndrome

Masi, D., Risi, R., Biagi, F., Vasquez Barahona, D., Watanabe, M., Zilich, R., Gabrielli, G., Santin, P., Mariani, S., Lubrano, C., et al. (2022) · Nutrients

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 20

Very low‐calorie ketogenic diet and liraglutide as a synergistic strategy for the treatment of obesity: A short‐term, non‐randomised, observational, real‐world clinical evaluation

Camajani, E., Masi, D., Spizzichini, M. L., Cori, C., Rossetti, R., Spoltore, M. E., Tuccinardi, D., Lubrano, C., Gnessi, L., Isidori, A. M., et al. (2025) · Diabetes, Obesity and Metabolism

Diet and metabolism studiesDietary Effects on Health

Cited by 7